Value through Innovation27 July 2016

Clinical Study Results

  • PEG 400 - Healthy
    Clinical Study Number 352.2030
    Study Indication Healthy
    Product PEG 400
    Generic Name PEG 400
    Lab Code
    Clinical Phase I
    Study Title

    Safety of total daily doses of 5, 10, 15 and 20 mL PEG 400 administered orally to healthy male human subjects once (QD) or twice (BID) for 14 days. A single center, multiple rising dose study, placebo controlled, double-blinded at each dose level.

    Study Document Trial synopsis 352.2030_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.